{"schema_version":"secwatch.filing_event.v1","accession":"0000200406-23-000043","form_type":"8-K","ticker":"JNJ","cik":"0000200406","company_name":"JOHNSON & JOHNSON","filed_at":"2023-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.656850+00:00","generated_at":"2026-06-17T00:56:33.850265+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"J&J Q1 revenue $24.7B (+5.6%), adj EPS $2.68 (+0.4%); raises FY guidance, increases dividend 5.3%","bullets":["GAAP net loss $68M ($0.03 loss per share) due to $7.2B one-time charge; adjusted net earnings $7,068M, adj EPS $2.68.","Revenue increased 5.6% to $24.7B; operational growth 9.0%; all segments grew: Consumer +7.4%, Pharma +4.2%, MedTech +7.3%.","Company raising 2023 full-year guidance midpoints for adjusted operational sales and adjusted operational EPS.","Board declared 5.3% dividend increase to $1.19/share ($4.76 annual); 61st consecutive year; payable June 6, record May 23."],"urls":{"canonical":"https://secwatch.observer/filing/0000200406-23-000043","json":"https://secwatch.observer/filing/0000200406-23-000043.json","markdown":"https://secwatch.observer/filing/0000200406-23-000043.md","text":"https://secwatch.observer/filing/0000200406-23-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/200406/000020040623000043/0000200406-23-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/200406/000020040623000043/jnj-20230418.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T00:56:33.850265+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"66c763fdb49abc145fb0b4d411985d4568a34328","claim":"JOHNSON & JOHNSON reported first quarter ended April 2, 2023 results: revenue $24.7 Billion, net income ($0.03), EPS $2.68. Guidance raised.","evidence_excerpt":"JOHNSON & JOHNSON REPORTS 2023 FIRST-QUARTER RESULTS: • 2023 First-Quarter reported sales growth of 5.6% to $24.7 Billion with operational growth of 9.0%* and adjusted operational growth of 7.6%* • 2023 First-Quarter basic loss per share of ($0.03) decreasing 101.6% due to a special one-time charge, with adjusted earnings per share (EPS) of $2.68 increasing by 0.4%* • Company is increasing 2023 full-year guidance midpoints for adjusted operational sales and adjusted operational EPS","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/200406/000020040623000043/0000200406-23-000043-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended April 2, 2023"},{"label":"Revenue","value":"$24.7 Billion"},{"label":"Net income","value":"($0.03)"},{"label":"EPS","value":"$2.68"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}